LIVE SESSION BRIEF Biotechnology $179M Cap Quant: HOLD

Seres Therapeutics, Inc. (MCRB) — Live Session & Technical Brief

Updated Nov 17, 2026 5:04 PM ET · Prev Close $1.41

Pro Workspace
Last Session Price
$1.41 +0.00%
+$0.00 vs $1.41 prior close
Intraday Range
$1.33 – $1.50
Open $1.39
Relative Volume
0.61x Avg
55,576 sh
52-Week Range
$1.30 – $29.98
Benchmark Alpha
+1.01% vs SPY
+0.73% vs QQQ
20-Session Trend -38.7%

Session Regime & Catalyst Assessment

64% Signal Conviction
TECHNICAL 64% Driver Weight

Controlled Session Consolidation (+0.00%) in Biotechnology

Seres Therapeutics, Inc. (MCRB) is trading within a tight intraday band at $1.41 (+0.00%, 0.61x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, MCRB is outperforming the S&P 500 by +1.01%. 14-day RSI stands at 23.8, keeping momentum in a oversold regime.

NEWS 70% Weight
Seres Therapeutics MCRB Reports Q3 Loss, Beats Revenue Estimates

Seres Therapeutics MCRB delivered earnings and revenue surprises of 20.90 and 196.50 , respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

TECHNICAL 68% Weight
Moving Average Structure: Bearish Alignment

Price ($1.41) trades relative to 20-day SMA ($1.81) and 50-day SMA ($2.79).

Volume Confirmation
LOW VOLUME (0.61x) Consolidation
Sub-average participation — monitor RVOL expansion above 1.2x.
Composite Catalyst Confidence 64%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

MCRB outperforming the S&P 500 by +1.01%
MCRB Session
+0.00%
$1.41
S&P 500 (SPY)
-1.01%
$732.44
Nasdaq 100 (QQQ)
-0.73%
$656.95
Healthcare (XLV)
-1.41%
$185.24
Alpha vs SPY: +1.01% Alpha vs QQQ: +0.73% Alpha vs XLV: +1.41%

Recent MCRB Catalyst Headlines

Verified Wire

1–3 Day Expected Range & Key Level

48% Follow-Through
Lower Bound
$1.38
Short-term support band
Upper Bound
$1.44
Short-term resistance band
Key Inflection Level
$1.50 (session resistance)

Monitor volume expansion above 1.5x RVOL around $1.50 (session resistance) for directional breakout confirmation.

Technical Regime (MCRB)

BEARISH MA TREND
RSI (14)
23.8
Oversold
20-Day SMA
$1.81
Below 20d
50-Day SMA
$2.79
Below 50d
MACD Signal
Bullish
MACD -0.37
ADX (14)
51.7
Strong trend
10d Momentum
-0.54
Soft 10-day momentum

Retail & Crowd Sentiment

Very Bullish
24h Messages
8
2.5x 7d avg
Bullish / Bearish
87.5% / 12.5%
Moderate buzz
Crowd Discussion Digest

StockTwits messages express bullish anticipation towards $MCRB, mentioning potential partnerships with companies such as $MRK, $BMS.X, $TAK, and $AZN. No recent news articles were available.

Reddit communities: 1 comment (Neutral)

About Seres Therapeutics, Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome …

Sector
Healthcare
Market Cap
$179M
Forward P/E
10.3x
Employees
103

Get Instant MCRB Catalyst Alerts

Receive an email alert when MCRB triggers an unusual volume breakout, options sweep, or rating shift.

Other Liquid Stocks Moving Today

All Today's Movers

MCRB Session & Catalyst FAQ

Why is MCRB stock trading near flat today?

Seres Therapeutics, Inc. (MCRB) is trading within a tight intraday band at $1.41 (+0.00%, 0.61x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, MCRB is outperforming the S&P 500 by +1.01%. 14-day RSI stands at 23.8, keeping momentum in a oversold regime.

Is MCRB stock a buy or sell right now?

Today's session carries a 64% catalyst conviction score on 0.61x relative volume (low participation). Our multi-factor model currently rates MCRB as HOLD. Review full valuation, quality, and timing signals on the MCRB Buy or Sell Decision Brief →

What is MCRB's intrinsic value and expected trading range?

At $1.41, MCRB's modeled 1-to-3 session range is $1.38 – $1.44, with a key inflection level at $1.50 (session resistance). Compare current price against multi-year cash flow projections in the MCRB Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →

What do RSI and moving averages signal for MCRB?

RSI at 23.8 indicates oversold conditions — watch for mean-reversion support. MCRB trades at $1.41 relative to its 20-day SMA ($1.81) and 50-day SMA ($2.79), reflecting a bearish moving-average structure.

Tradestie Flagship Research & Market Hubs